Alan Linn Murphree, MD, FACS

Dr. Alan Linn Murphree, MD, FACS


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Genes
Verified
Journal Article
Open access
PDF file
Jesse BerryJesse Berry
Jesse Berry
APAshley Polski
Ashley Polski
WCWebster Cavenee
Webster Cavenee
TDThaddeus P. Dryja
Thaddeus P. Dryja
AFAlan Linn Murphree, MD, FACS
Alan Linn Murphree, MD, FACS
BGBrenda Gallie
Brenda Gallie
The RB1 gene is the first described human tumor suppressor gene and plays an integral role in the development of retinoblastoma, a pediatric malignancy of the eye. Since its discovery, the stepwise characterization and cloning of RB1 have laid the foundation for numerous advances in the understanding of tumor suppressor genes, retinoblastoma tumorigenesis, and inheritance. Knowledge of RB1 led to a paradigm shift in the field of cancer genetics, including widespread acceptance of the concept of tumor suppressor genes, and has provided crucial diagnostic and prognostic information through genetic testing for patients affected by retinoblastoma. This article reviews the long history of RB1 gene research, characterization, and cloning, and also discusses recent advances in retinoblastoma genetics that have grown out of this foundational work.